Several antineoplastic drugs induce severe toxic damage of the peripheral nervous system and chemotherapy-induced peripheral neurotoxicity (CIPN) can be dose limiting. Moreover, CIPN signs and symptoms can be permanent and severely impair the patients' quality of life even after drug withdrawal. Despite extensive investigation, the exact mechanisms of neurotoxic action at the basis of CIPN are not completely known and it is likely that they can be at least in part different from the mechanisms of antineoplastic action of the drugs. A possible instrument to investigate on this important issue is represented by the evaluation of the effect of compounds used to reduce the toxicity of antineoplastic drugs in pre-clinical and clinical settings. This review will be focused on the most clinically-relevant neurotoxic antineoplastic drugs and on the results obtained with several different classes of putative neuroprotectants.

Cavaletti, G., Nicolini, G., Marmiroli, P. (2008). Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies. FRONTIERS IN BIOSCIENCE, 13(9), 3506-3524 [10.2741/2945].

Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies

CAVALETTI, GUIDO ANGELO;NICOLINI, GABRIELLA;MARMIROLI, PAOLA LORENA
2008

Abstract

Several antineoplastic drugs induce severe toxic damage of the peripheral nervous system and chemotherapy-induced peripheral neurotoxicity (CIPN) can be dose limiting. Moreover, CIPN signs and symptoms can be permanent and severely impair the patients' quality of life even after drug withdrawal. Despite extensive investigation, the exact mechanisms of neurotoxic action at the basis of CIPN are not completely known and it is likely that they can be at least in part different from the mechanisms of antineoplastic action of the drugs. A possible instrument to investigate on this important issue is represented by the evaluation of the effect of compounds used to reduce the toxicity of antineoplastic drugs in pre-clinical and clinical settings. This review will be focused on the most clinically-relevant neurotoxic antineoplastic drugs and on the results obtained with several different classes of putative neuroprotectants.
Articolo in rivista - Articolo scientifico
neurotoxicity, antineoplastic drugs
English
1-mag-2008
13
9
3506
3524
none
Cavaletti, G., Nicolini, G., Marmiroli, P. (2008). Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies. FRONTIERS IN BIOSCIENCE, 13(9), 3506-3524 [10.2741/2945].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/12508
Citazioni
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 27
Social impact